SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-21-011504
Filing Date
2021-03-08
Accepted
2021-03-08 16:30:28
Documents
13
Period of Report
2021-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A drrx-8ka_20210304.htm   iXBRL 8-K/A 34835
2 EX-99.1 drrx-ex991_6.htm EX-99.1 400199
  Complete submission text file 0001564590-21-011504.txt   586321

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA drrx-20210304.xsd EX-101.SCH 5768
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20210304_lab.xml EX-101.LAB 19430
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20210304_pre.xml EX-101.PRE 11609
6 EXTRACTED XBRL INSTANCE DOCUMENT drrx-8ka_20210304_htm.xml XML 3820
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-31615 | Film No.: 21722355
SIC: 2834 Pharmaceutical Preparations